only marginally significantP = .080
However, the difference between patients with TBD and controls was only marginally significant following false-discovery rate correction (3.9% ± 8.5% of CD3 + vs 7.4% ± 8.2% of CD3 + in controls; P = .080).
However, the difference between patients with TBD and controls was only marginally significant following false-discovery rate correction (3.9% ± 8.5% of CD3 + vs 7.4% ± 8.2% of CD3 + in controls; P = .080).